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Purpose: This analysis was done to investigate the optimal regimen for fentanyl-
based intravenous patient-controlled analgesia (IV-PCA) by finding a safe and ef-
fective background infusion rate and assessing the effect of adding adjuvant drugs 
to the PCA regimen. Materials and Methods: Background infusion rate of fen-
tanyl, type of adjuvant analgesic and/or antiemetic that was added to the IV-PCA, 
and patients that required rescue analgesics and/or antiemetics were retrospective-
ly reviewed in 1827 patients who underwent laparoscopic abdominal surgery at a 
single tertiary hospital. Results: Upon multivariate analysis, lower background in-
fusion rates, younger age, and IV-PCA without adjuvant analgesics were identified 
as independent risk factors of rescue analgesic administration. Higher background 
infusion rates, female gender, and IV-PCA without additional 5HT3 receptor 
blockers were identified as risk factors of rescue antiemetics administration. A 
background infusion rate of 0.38 µg/kg/hr [area under the curve (AUC)  0.638] or 
lower required rescue analgesics in general, whereas, addition of adjuvant analge-
sics decreased the rate to 0.37 µg/kg/hr (AUC 0.712) or lower. A background infu-
sion rate of 0.36 µg/kg/hr (AUC 0.638) or higher was found to require rescue anti-
emetics in general, whereas, mixing antiemetics with IV-PCA increased the rate to 
0.37 µg/kg/hr (AUC 0.651) or higher. Conclusion: Background infusion rates of 
fentanyl between 0.12 and 0.67 µg/kg/hr may safely be used without any serious 
side effects for IV-PCA. In order to approach the most reasonable background in-
fusion rate for effective analgesia without increasing postoperative nausea and 
vomiting, adding an adjuvant analgesic and an antiemetic should always be con-
sidered.
Key Words:   Analgesia, patient-controlled, fentanyl, background infusion rate, ad-
juvant drug
INTRODUCTION
Of various methods that are used for acute postoperative pain control, intravenous 
patient-controlled analgesia (IV-PCA) is the most commonly employed modality 
in modern medicine.1 Despite the lack of consensus on the appropriate dose of opi-
oids or the use of adjuvants, IV-PCA has already become standard practice for 
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of any side effects. A sedation level of 3 or 4 on the Pasero 
Opioid-Induced Sedation Scale7 was defined as unaccept-
able sedation, and respiratory depression was defined as 
ventilator frequency of less than 10 breaths per minute or 
oxygen saturation less than 90% when monitoring was ap-
plied. Rescue drugs were given according to the hospital 
protocol. Patients were administered rescue analgesics when 
reported pain scores were higher than 4 on a 10 mm visual 
analogue scale (0: no pain, 10: worst imaginable pain) or 
upon patient request. Ketorolac (Keromin®, Hana Pharm. 
Co., Seoul, Korea) 30 mg, or pethidine (Pethidine®, Jeil 
Pharmaceutical Co. Ltd., Daegu, Korea) 25 mg were given 
as rescue analgesics depending on pain character and pa-
tient characteristics. Rescue antiemetics were given when 
patients reported nausea scores higher than 4 on an 11-point 
verbal numerical rating scale (0: no nausea, 10: worst imag-
inable nausea), when retching or vomiting developed or by 
patient request. Metoclopramide (Macperan®, Dong Wha 
Pharm. Co., Ltd., Seoul, Korea) 10 mg was given as the 1st 
line rescue antiemetics, and patients with persistent and re-
fractory postoperative nausea and vomiting (PONV) were 
given 5-HT3 receptor antagonists such as ondansetron (On-
seran®, Yuhan, Seoul, Korea) 4 mg or ramosetron (Nasea®, 
Astellas Pharma Korea, Seoul, Korea) 0.3 mg. 
A total of 2548 consecutive patients who used a fentanyl-
based IV-PCA after laparoscopic abdominal surgery be-
tween September 2010 and August 2012 were identified 
and screened for eligibility for analysis. Among these pa-
tients, only those who had an IV-PCA device programmed 
to use 2 mL/hr for background infusion, a demand volume 
of 0.5 mL, and a lock-out interval of 15 minutes with a total 
volume of 100 mL were included in this study. Exclusion cri-
teria included patients who required postoperative intensive 
care unit (ICU) care, and patients who were administered 
routine analgesics and antiemetics on a regular basis. Pa-
tient age, gender, body mass index (BMI), American Soci-
ety of Anesthesiologist class, comorbidities, additional risk 
factors of PONV (e.g., history of smoking, motion sickness 
and PONV) and anesthesia duration were analyzed by elec-
tronic medical record review. The background infusion 
rates of fentanyl, type of adjuvant analgesic and/or anti-
emetic that were added to the IV-PCA regimen and patients 
who required rescue analgesics and/or antiemetics were 
also reviewed and analyzed according to the PCA manage-
ment team database. We also identified independent risk 
factors of rescue analgesic or antiemetic administration dur-
ing postoperative 48 hours. Based on the PCA-related data 
postoperative pain control in most hospitals. Moreover, it 
has been reported that most patients prefer IV-PCA over 
other methods, with high satisfaction scores.2,3 
Many studies have been undertaken to determine the ideal 
IV-PCA regimen that would maximize pain relief and mini-
mize opioid-related side effects at the same time.1,4,5 Wheth-
er or not to use a background infusion rate or add an adju-
vant drug to the IV-PCA are among the most debated issues 
regarding the application of IV-PCA. However, most clini-
cal studies dealing with these issues were done with mor-
phine-based regimens, as it is the most commonly used opi-
oid.1,4 Although fentanyl is considered as appropriate and 
perhaps better suited than morphine for IV-PCA due to its 
rapid onset and short duration of action,4,6 there is a relative 
shortage of evidence regarding its proper use in IV-PCA. 
The department of anesthesia of our hospital has been us-
ing fentanyl-based IV-PCA with background infusion for 
several years. However, PCA regimens were liberally decid-
ed by the attending anesthesiologist’s preference and judg-
ment, which resulted in a wide range of background infusion 
rates of fentanyl and different mixtures of analgesics and an-
tiemetics. Due to this heterogeneity of IV-PCA regimens, a 
question of whether there was a significant difference in an-
algesic efficacy or complication rates between regimens 
with different background infusion rates or adjuvant drugs 
remains largely unclear. This retrospective analysis attempt-
ed to analyze the regimens that were used for IV-PCA in a 
large number of patients who underwent laparoscopic ab-
dominal surgery at a single tertiary hospital, and investigate 
a more optimal regimen for fentanyl-based IV-PCA in terms 
of background infusion rates and adjuvant drugs. 
MATERIALS AND METHODS
　　　
This study is a retrospective analysis of patients who re-
ceived a fentanyl-based IV-PCA with background infusion 
after laparoscopic surgery. The study protocol was approved 
by the Institutional Review Board and Hospital Research 
Ethics Committee of Severance Hospital. The data used for 
this study was from a database which was prospectively 
compiled by a dedicated PCA management team that con-
sisted of two trained nurses. The PCA management team 
was trained to do ward rounds twice a day in every patient 
who was connected to any form of PCA device after surgery 
in order to evaluate the quality of pain control, need for ad-
ditional rescue analgesics or antiemetics and the presence 
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were also added in the analysis. First, univariate logistic re-
gression analysis was performed to identify significant pre-
dictors of rescue analgesic or antiemetic administration us-
ing the aforementioned variables. The factors that had a 
p-value of <0.05 were then included in the multivariate lo-
gistic regression analysis, as well as the demographic data, 
known risk factors of PONV, anesthesia duration, back-
ground infusion rate and the presence of adjuvant analgesics 
or antiemetics in the IV-PCA. Odds ratios and associated 
95% confidence intervals were estimated. Receiver operat-
ing characteristic (ROC) curve analysis was performed to 
obtain cutoff values of background infusion rates that would 
require rescue analgesics and antiemetics. Optimal cutoff 
values were determined on the basis of the maximum values 
of the Youden index, calculated by [sensitivity+specificity-1]. 
All analyses were performed with SPSS for Windows ver-
sion 20.0 (IBM SPSS Inc., Chicago, IL, USA). p<0.05 was 
considered to be significant.
 
RESULTS
 
Of the 2548 consecutive patients that were identified, 434 
patients who used a background infusion rate of 1 mL/hr, 
118 patients who required ICU care, and an additional 169 
patients who were administered routine analgesics and anti-
emetics on a regular basis were excluded, leaving 1827 pa-
tients eligible for analysis. The flowchart for patient sample 
selection is shown in Fig. 1. Patient characteristics which 
include demographic data, risk factors for PONV and PCA-
related data are shown in Table 1. Of the 1827 patients, 484 
(26.5%) patients received an IV-PCA containing adjuvant 
analgesics. 455 (94.0%) of these patients received 90 to 
120 mg of ketorolac (Keromin®, Hana Pharm. Co., Seoul, 
Korea) and the remaining 29 (6.0%) received 120 to 160 
mg of nefopam (Acupan®, Pharmbio Korea, Seoul, Korea). 
5HT3 receptor antagonists were added as antiemetics in 
1668 (91.3%) patients; 1037 (62.2%) of these patients re-
ceived 8 to 12 mg of ondansetron (Onseran®, Yuhan, Seoul, 
Korea) and 631 (37.8%) received 0.3 to 0.6 mg of ramose-
tron (Nasea®, Astellas Pharma Korea, Seoul, Korea). The 
background infusion rate of fentanyl ranged between 0.12 
and 0.67 µg/kg/hr.
The number of patients who required rescue analgesics at 
least once during the post-operative 48 hour period were 
1464 (80.1%), and 1063 (58.2%) patients were adminis-
tered multiple doses of analgesics. The number of patients 
that was collected, we analyzed and compared the cutoff 
value of fentanyl background infusion rate that would re-
quire rescue analgesics or antiemetics between patients who 
received IV-PCA with or without adjuvant analgesics or an-
tiemetics. 
       
Statistical analysis
Continuous variables are shown as mean±SD and categorical 
variables are shown as numbers (percentage). To identify in-
dependent predictors of rescue analgesic or antiemetic ad-
ministration, a logistic regression model was used. Potential 
confounding factors for analysis were selected on the basis of 
literature review and included demographic data (gender, 
age, BMI), underlying medical diseases (hypertension, dia-
betes mellitus), known risk factors of PONV (history of 
smoking, motion sickness and PONV) and anesthesia dura-
tion. Background infusion rate and the factors of whether ad-
juvant analgesics or antiemetics were added in the IV-PCA 
Fig. 1. Flowchart for patient sample selection. ICU, intensive care unit.
Table 1. Characteristics of Patients That Received Postpera-
tive Intravenous Patient-Controlled Analgesia 
Parameter
Male sex   731 (40.0)
Age (yrs)   53.9±14.2
BMI (kg/m2) 23.2±3.4
History of motion sickness 145 (7.9)
History of PONV   17 (0.9)
History of smoking   302 (16.5)
PCA with additional analgesics   484 (26.5)
PCA with antiemetics 1668 (91.3)
Anesthesia duration (min)   295.3±221.7
BMI, body mass index; PONV, postoperative nausea and vomiting; PCA, 
patient-controlled analgesia. 
Values are mean±SD or n (%) of patients.
Background infusion rate of 1 mL/hr 
(n=434)
Routine analgesics or antiemetics 
administration (n=169)
Post-operative ICU care (n=118)
Total 2548 patients
1827 patients
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fusion rate of 0.38 µg/kg/hr [area under the curve (AUC) 
0.638] or lower required rescue analgesics in general. How-
ever, background infusion rates that would require rescue 
analgesics with and without adjuvant analgesics in the IV-
PCA were 0.37 µg/kg/hr (AUC 0.712) or lower and 0.38 
µg/kg/hr (AUC 0.619) orlower, respectively (Table 4). A 
background infusion rate of 0.36 µg/kg/hr (AUC 0.638) or 
higher was found to require rescue antiemetics in general, 
while mixing antiemetics to the IV-PCA increased the rate 
to 0.37 µg/kg/hr (AUC 0.651) or higher. However, a back-
ground infusion rate of 0.34 µg/kg/hr (AUC 0.611) or high-
er was found to require rescue antiemetics without anti-
emetics in the IV-PCA (Table 5).
DISCUSSION
Although many clinicians and patients now prefer to use 
IV-PCA over other modalities for postoperative pain control, 
there is still a considerable amount of debate over whether 
or not to use background infusions and combine adjuvant 
who were administered rescue analgesics was highest dur-
ing the postoperative 1 to 6 hour period and gradually de-
creased thereafter. The mean frequency of rescue analgesic 
administration per patient was highest during the postoper-
ative 1 to 6 hour period. PONV was reported in 467 (25.6%) 
patients, and 275 (15.1%) patients required rescue anti-
emetics. 88 (4.8%) patients were administered multiple 
doses of antiemetics. The number of patients who were ad-
ministered rescue antiemetics was highest during postoper-
ative 1 to 6 hours. Other side effects such as dizziness, se-
dation, headache and pruritus were reported in 105 (5.8%), 
43 (2.4%), 26 (1.4%) and 16 (0.9%) patients, respectively. 
Respiratory depression was not found in any of the patients. 
Upon multivariate analysis, lower background infusion 
rates, younger age and IV-PCA without adjuvant analgesics 
were identified as independent risk factors of rescue analge-
sic administration (Table 2). Higher background infusion 
rates, female gender, and IV-PCA without additional 5HT3 
receptor blockers were identified as risk factors of rescue 
antiemetics administration (Table 3). 
According to the ROC curve analysis, a background in-
Table 2. Risk Factors of Rescue Analgesics Requirement According to Logistic Regression Analysis
Predictors Odds ratio 95% CI p value
Background infusion rate  
  (per 0.01 µg/kg/hr)
0.968 0.950-0.986 <0.001
Male sex 0.718 0.490-1.053   0.090
Age (yrs) 0.987 0.975-0.999   0.031
BMI (kg/m2) 1.022 0.977-1.070   0.344
PCA with adjuvant analgesics 0.548 0.393-0.766 <0.001
PCA with antiemetics 1.085 0.717-1.640   0.701
History of smoking 0.888 0.590-1.336   0.568
History of motion sickness 0.966 0.493-1.892   0.919
History of PONV 2.673   0.308-23.242   0.373
Anesthesia duration (per 1 min) 1.000 0.999-1.000   0.385
BMI, body mass index; PCA, patient-controlled analgesia; PONV, postoperative nausea and vomiting; CI, confidence interval.
Table 3. Risk Factors of Rescue Antiemetics Requirement According to Logistic Regression Analysis
Predictors Odds ratio 95% CI p value
Background infusion rate 
  (per 0.01 µg/kg/hr)
1.061 1.036-1.086 <0.001
Male sex 0.094 0.048-0.186 <0.001
Age (yrs) 1.003 0.989-1.018   0.653
BMI (kg/m2) 1.009 0.958-1.063   0.740
PCA with adjuvant analgesics 0.781 0.502-1.214   0.272
PCA with antiemetics 0.429 0.271-0.681 <0.001
History of smoking 0.559 0.247-1.268   0.164
History of motion sickness 1.788 0.958-3.245   0.056
History of PONV 1.298 0.316-5.333   0.718
Anesthesia duration (per 1 min) 0.999 0.998-1.000   0.064
BMI, body mass index; PCA, patient-controlled analgesia; PONV, postoperative nausea and vomiting; CI, confidence interval.
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cent studies that employed a background infusion rate of 
fentanyl in IV-PCA did not find any cases of respiratory de-
pression,22,23 even at a relatively high rate of 0.4 µg/kg/h.23 
While these studies provide supportive evidence regarding 
the use of fentanyl with background infusion in IV-PCA, 
they were not able to offer any guideline as to how to mix 
the IV-PCA regimen to achieve both effective pain relief 
and a low incidence of PONV.   
In the present analysis, lower background infusion rate 
and PCA without adjuvant analgesics were identified as 
significant risk factors of rescue analgesic administration. 
However, higher background infusion rates decreased the 
administration of rescue analgesics, while it reversely in-
creased the risk of rescue antiemetic administration. Natu-
rally, mixing antiemetics in the IV-PCA was found to de-
crease the risk of rescue antiemetic requirements. Overall, 
these results offer a rationale to mix both adjuvant analge-
sics and antiemetics to the IV-PCA in order to improve pain 
relief and decrease PONV. Combining different classes of 
analgesics in order to improve pain relief and decrease drug-
related adverse effects has been coined ‘multimodal analge-
sia’,24 and various drugs have been evaluated as possible 
adjuvants to opioids in IV-PCA regimens.4,8 Despite incon-
sistent results and scarcity of large-scale prospective ran-
domized trials, there is a clear trend towards the use of this 
technique in postoperative pain management25,26 and some 
authors even recommend that multimodal analgesia should 
be used whenever possible.27 The risk factor analysis of the 
present study is in context with this concept, and also shows 
that adding an antiemetic may decrease the risk of PONV 
in patients using fentanyl-based IV-PCA. 
The results of the present study seem meaningful in that 
analgesics. Using background infusion for IV-PCA has been 
discouraged by many due to the risk of respiratory depres-
sion without any improvement in pain relief,8 although some 
found otherwise.9,10 The employment of multimodal analge-
sia with the intention of achieving opioid-sparing effects has 
been extensively studied, with inconsistent results.11,12 Our 
present retrospective analysis showed that a wide range of 
background infusion rate of fentanyl between 0.12 and 0.67 
µg/kg/hr was being used for IV-PCA without causing se-
vere adverse effects. Most importantly, adding both an ad-
juvant analgesic and an antiemetic to the IV-PCA regimen 
was found to simultaneously decrease the background infu-
sion rate required for effective pain relief as well as the in-
cidence of PONV.  
Most of the previous studies that assessed the safety and 
efficacy of postoperative IV-PCA with background infusion 
were conducted in morphine-based regimens.13-16 Morphine 
has been the most widely used opioid in IV-PCA for a long 
time, and several studies showed evidence of safe and ef-
fective background infusion rates of morphine.9,10,17,18 On 
the other hand, little is known about appropriate background 
infusion rates of fentanyl when used in postoperative IV-
PCA. A highly lipophilic drug without any active metabo-
lites, fentanyl offers a wider therapeutic index than mor-
phine.19 While the use of morphine background infusion is 
basically criticized and discouraged based on the risk of 
overmedication and respiratory depression,8,16 the different 
pharmacokinetic properties of fentanyl may cause the pa-
tient to redose frequently or include background infusion as 
part of the PCA setting.1 In terms of safety, fentanyl has been 
reported to cause less respiratory depression and other opi-
oid-related side effects compared to morphine.20,21 Two re-
Table 4. Cutoff Value of Background Infusion Rate for Rescue Analgesic Requirement
Cutoff 
value
AUC
Sensitivity 
(%)
Specificity 
(%)
Youden 
index
95% CI p value
All PCA 0.38 0.638 72.5 50.4 0.229 0.607-0.670 <0.001
PCA without adjuvant analgesics 0.38 0.619 67.5 54.4 0.220 0.581-0.657 <0.001
PCA with adjuvant analgesics 0.37 0.712 86.9 41.6 0.285 0.659-0.765 <0.001
PCA, patient-controlled analgesia; AUC, area under the curve; CI, confidence interval.
Table 5. Cutoff Value of Background Infusion Rate for Rescue Antiemetic Requirement
Cutoff 
value
AUC
Sensitivity 
(%)
Specificity 
(%)
Youden 
index
95% CI p value
All PCA 0.36 0.638 55.3 69.3 0.246 0.620-0.686 <0.001
PCA without antiemetics 0.34 0.611 63.6 53.9 0.175 0.543-0.678   0.003
PCA with antiemetics 0.37 0.651 53.0 72.0 0.250 0.615-0.693 <0.001
PCA, patient-controlled analgesia; AUC, area under the curve; CI, confidence interval.
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cidence of PONV. A randomized controlled trial without a 
skewed pattern of background infusion rates are needed for 
more supportive evidence. Secondly, the total consumed 
amount of analgesics per time unit or the frequency and 
amount of bolus doses on demand could not be analyzed due 
to retrospective design of the present study. We were only 
able to evaluate the quality of analgesia by comparing the 
frequency of rescue analgesic administration as a surrogate. 
Lastly, the types of adjuvant drugs or surgery were not con-
trolled in the present analysis. A well designed randomized 
controlled trial should be able to provide more insight into 
effective procedure-specific regimens in the future. 
Important as it is for safe and effective analgesia, it is 
clear that finding the ‘ideal’ regimen for fentanyl-based IV-
PCA is a difficult task. The results of the present study 
show that background infusion rates of fentanyl between 
0.12 and 0.67 µg/kg/hr may be safely used without any se-
rious side effects such as respiratory depression for IV-PCA. 
However, in order to approach the most reasonable back-
ground infusion rate that can offer effective analgesia with-
out increasing PONV, adding an adjuvant analgesic regard-
less of its drug class together with an antiemetic should be 
always considered. 
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